Effect of Universal Testing and Treatment on HIV Incidence — HPTN 071 (PopART)

Abstract

BACKGROUND: A universal testing and treatment strategy is a potential approach to reduce the incidence of human immunodeficiency virus (HIV) infection, yet previous trial results are inconsistent. METHODS: In the HPTN 071 (PopART) community-randomized trial conducted from 2013 through 2018, we randomly assigned 21 communities in Zambia and South Africa (total population, approximately 1 million) to group A (combination prevention intervention with universal antiretroviral therapy [ART]), group B (the prevention intervention with ART provided according to local guidelines [universal since 2016]), or group C (standard care). The prevention intervention included home-based HIV testing delivered by community workers, who also supported linkage to HIV care and ART adherence. The primary outcome, HIV incidence between months 12 and 36, was measured in a population cohort of approximately 2000 randomly sampled adults (18 to 44 years of age) per community. Viral suppression (<400 copies of HIV RNA per milliliter) was assessed in all HIV-positive participants at 24 months. RESULTS: The population cohort included 48,301 participants. Baseline HIV prevalence was 21% or 22% in each group. Between months 12 and 36, a total of 553 new HIV infections were observed during 39,702 person-years (1.4 per 100 person-years; women, 1.7; men, 0.8). The adjusted rate ratio for group A as compared with group C was 0.93 (95% confidence interval [CI], 0.74 to 1.18; P = 0.51) and for group B as compared with group C was 0.70 (95% CI, 0.55 to 0.88; P = 0.006). The percentage of HIV-positive participants with viral suppression at 24 months was 71.9% in group A, 67.5% in group B, and 60.2% in group C. The estimated percentage of HIV-positive adults in the community who were receiving ART at 36 months was 81% in group A and 80% in group B. CONCLUSIONS: A combination prevention intervention with ART provided according to local guidelines resulted in a 30% lower incidence of HIV infection than standard care. The lack of effect with universal ART was unanticipated and not consistent with the data on viral suppression. In this trial setting, universal testing and treatment reduced the population-level incidence of HIV infection. (Funded by the National Institute of Allergy and Infectious Diseases and others; HPTN 071 [PopArt] ClinicalTrials.gov number, NCT01900977.).

Shown for reading. Its publisher allows quoting it, not republishing it.

References 33

1. 1.

   UNAIDS Fact Sheet World AIDS Day Accesssed 21st January 2019 2018.

   Not in our library

2. 2.

   UNAIDS Miles to go—closing gaps, breaking barriers, righting injustices. http://wwwunaidsorg/sites/default/files/media_asset/miles-to-go_enpdf 2018;Accessed 21st January 2019.

   Not in our library

3. 3.

   Granich R, Crowley S, Vitoria M, et al. Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Current opinion in HIV and AIDS 2010;5:298-304.

   Not in our library10.1097/coh.0b013e32833a6c32

4. 4.

   Chang LW, Serwadda D, Quinn TC, Wawer MJ, Gray RH, Reynolds SJ Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects. The Lancet infectious diseases 2013;13:65-76.

   Not in our library10.1016/s1473-3099(12)70273-6

5. 5.

   Cohen MS, Chen YQ, McCauley M, et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. The New England journal of medicine 2016;375:830-9.

   Not in our library10.1056/nejmoa1600693

6. 6.

   Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. The New England journal of medicine 2011;365:493-505.

   Not in our library10.1056/nejmoa1105243

7. 7.

   Rodger AJ, Cambiano V, Bruun T, et al. Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. JAMA 2016;316:171-81.

   Not in our library10.1001/jama.2016.5148

8. 8.

   Rodger AJ, Cambiano V, Bruun T, et al. Risk of HIV transmission through condomless sex in MSM couples with suppressive ART: The PARTNER2 Study extended results in gay men. 22nd International AIDS conference, Amsterdam 2018;Abstract no WEAX0104LB:Accessed 21st January 2019.

   Not in our library

9. 9.
   HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa · 2012

   No notice
10. 10.

    Granich R, Crowley S, Vitoria M, et al. Highly active antiretroviral treatment for the prevention of HIV transmission. Journal of the International AIDS Society 2010;13:1.

    Not in our library10.1186/1758-2652-13-1

11. 11.

    Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009;373:48-57.

    Not in our library10.1016/s0140-6736(08)61697-9

12. 12.

    TEMPRANO ANRS Study Group A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine 2015;373:808-22.

    Not in our library10.1056/nejmoa1507198

13. 13.

    INSIGHT START Study Group Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. The New England journal of medicine 2015;373:795-807.

    Not in our library10.1056/nejmoa1506816

14. 14.

    World Health Organization Guideline on when to start Antiretroviral therapy and on Pre-exposure Prophylaxis for HIV. http://appswhoint/iris/bitstream/10665/186275/1/9789241509565_engpdf?ua=1 2015;Accessed on 26th February 2016.

    Not in our library

15. 15.

    UNAIDS 90-90-90: An ambitious treatment target to help end the AIDS epidemic. http://wwwunaidsorg/sites/default/files/media_asset/90-90-90_en_0pdf 2014;Accessed on 11th January 2016.

    Not in our library

16. 16.

    Iwuji CC, Orne-Gliemann J, Larmarange J, et al. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. Lancet HIV 2018;5:e116-e25.

    Not in our library10.1016/s2352-3018(17)30205-9

17. 17.

    Havlir D, Charlebois E, Balzer L, et al. SEARCH community cluster randomized study of HIV “test and treat” using multi-disease approach and streamlined care in rural Uganda and Kenya. 22nd International AIDS conference, Amsterdam 2018;Abstract no WEAX0106LB:Accessed 21st January 2019.

    Not in our library

18. 18.

    Makhema MJ, Wirth K, Pretorius Holme M, et al. Impact of prevention and treatment interventions on population HIV incidence: Primary results of the community-randomized Ya Tsie Botswana prevention project. 22nd International AIDS conference, Amsterdam 2018;Abstract no WEAX0105LB Accessed on 21st January 2019

    Not in our library

19. 19.
    HPTN 071 (PopART): Rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment – a study protocol for a cluster randomised trial · 2014

    No notice
20. 20.

    Cori A, Ayles H, Beyers N, et al. HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model. PloS one 2014;9:e84511.

    Not in our library10.1371/journal.pone.0084511

21. 21.

    Donnell D, Floyd S, Hayes R, HPTN 071 Protocol Team HPTN 071 (PopART) Study Statistical Analysis Plan. https://www.hptnorg/sites/default/files/2019-01/HPTN071_SAP_v30_16Dec2018pdf 2018;Accessed 27th January 2019.

    Not in our library

22. 22.

    Eldridge S, Kerry S A Practical Guide to Cluster Randomised Trials in Health Services Research. DOI: 2012;Copyright © 2012 John Wiley & Sons, Ltd.

    Not in our library10.1002/9781119966241

23. 23.

    Hayes R, Moulton L Cluster Randomised Trials. doiorg/104324/9781315370286 2017;New York: Chapman and Hall/CRC.

    Not in our library

24. 24.

    Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 2013;339:966-71.

    Not in our library10.1126/science.1228160

25. 25.

    Tanser F, Vandormael A, Cuadros D, et al. Effect of population viral load on prospective HIV incidence in a hyperendemic rural African community. Sci Transl Med 2017;9.

    Not in our library10.1126/scitranslmed.aam8012

26. 26.

    Justman JE, Mugurungi O, El-Sadr WM HIV Population Surveys - Bringing Precision to the Global Response. The New England journal of medicine 2018;378:1859-61.

    Not in our library10.1056/nejmp1801934

27. 27.

    Eisinger RW, Dieffenbach CW, Fauci AS HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable. JAMA: the journal of the American Medical Association 2019.

    Not in our library10.1001/jama.2018.21167

28. 28.

    Fayorsey RN, Wang C, Chege D, et al. Effectiveness of a Lay Counselor-Led Combination Intervention for Retention of Mothers and Infants in HIV Care: A Randomized Trial in Kenya. J Acquir Immune Defic Syndr 2019;80:56-63.

    Not in our library10.1097/qai.0000000000001882

29. 29.

    Hargreaves JR, Delany-Moretlwe S, Hallett TB, et al. The HIV prevention cascade: integrating theories of epidemiological, behavioural, and social science into programme design and monitoring. Lancet HIV 2016;3:e318-22.

    Not in our library10.1016/s2352-3018(16)30063-7

30. 30.

    Krishnaratne S, Hensen B, Cordes J, Enstone J, Hargreaves JR Interventions to strengthen the HIV prevention cascade: a systematic review of reviews. Lancet HIV 2016;3:e307-17.

    Not in our library10.1016/s2352-3018(16)30038-8

31. 31.

    Hayes R, Floyd S, Schaap A, et al. A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial. PLoS Med 2017;14:e1002292.

    Not in our library10.1371/journal.pmed.1002292

32. 32.

    Floyd S, Ayles H, Schaap A, et al. Towards 90-90: Findings after two years of the HPTN 071 (PopART) cluster-randomized trial of a universal testing-and-treatment intervention in Zambia. PloS one 2018;13:e0197904.

    Not in our library10.1371/journal.pone.0197904

33. 33.

    Stopard IJ, McGillen JB, Hauck K, Hallett TB The influence of constraints on the efficient allocation of resources for HIV prevention: a modelling study. AIDS 2019.

    Not in our library10.1097/qad.0000000000002158

Cited by papers we hold 3

• Achieving the 95 95 95 targets for all: A pathway to ending AIDS · 2022
  Corrected
• HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial. · 2020
  Not checked
• Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.